Physician profile
Aric D Hausknecht
NPI 1508942046
$3,058.41
in general payments reported to CMS, 2019-2025
12 companies · $589 in 2025
The $589 reported for 2025 was more than what 78% of Neuromusculoskeletal Medicine, Sports Medicine providers received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $410 · 2021: $509 · 2022: $155 · 2023: $301 · 2024: $287 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,176.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,068.76 | 2021-2025 | |
| Nevro Corp. | $731.90 | 2019-2024 | Senza |
| Amgen INC. | $497.06 | 2019-2021 | |
| Vertiflex, INC. | $181.44 | 2019 | |
| Globus Medical, INC. | $163.44 | 2025 | Senza |
| Medtronic, INC. | $129.17 | 2022-2025 | Percept Pc Brainsense |
| Allergan, INC. | $99.22 | 2019-2022 | |
| Redhill Biopharma INC. | $83.96 | 2020 | |
| Medtronic USA, INC. | $43.17 | 2019 | |
| Collegium Pharmaceutical, INC. | $36.40 | 2020 | |
| Horizon Therapeutics Plc | $12.33 | 2019 | |
| Pfizer INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aric Hausknecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.